methyl 2-bromopentanoate

We are methyl 2-bromopentanoate CAS:19129-92-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:methyl 2-bromopentanoate
CAS.NO:19129-92-1
Synonyms:methyl 2-bromo-butyric acid methyl ester
2-bromo-pentanoic acid methyl ester
Molecular Formula:C6H11BrO2
Molecular Weight:195.05400
 
Physical and Chemical Properties:
Density:1.349;
Boiling point:179-372oC;
Flash point:69.549oC;
Index of Refraction:1.455;
 
Specification:
Appearance:Colorless clear liquid
Purity(GC):≥98.5%
Moisture:≤0.1%
 
Packing:250 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As an intermediate in organic synthesis
 

methyl 2-bromopentanoate


Related News: The fine chemical industry includes fine chemicals and special chemicals. Fine chemical products have the characteristics of a small amount of production, relatively specific application fields, and long and complex industrial chains. They are mainly used in medicine, pesticides, dyes, liquid crystals and other fields.2-bromo-9,10-difenilantraceno CAS:201731-79-5 Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the global pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules.Ácido 3- (3-metil-5-oxo-4H-pirazol-1-il) bencenosulfónico CAS:119-17-5 Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the global pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules.5441-61-2 Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the global pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules.Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL.

Related Products
Product Name
2-isocyanatoethyl 2-methylprop-2-enoate View Details
Ethyl 2-Bromoisovalerate View Details
3,4,5,6-Tetrahydrophthalic anhydride View Details
4-Trifluoromethoxytoluene manufacturer Bromoacetaldehyde dimethyl acetal manufacturer tert-Butylchlorodiphenylsilane manufacturer 2-Amino-5-fluorobenzonitrile manufacturer 6-Methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine manufacturer